# Alamar Biosciences, Inc.: Form SCHEDULE 13D/A, filed Jul 7, 2026

- Company: [Alamar Biosciences, Inc.](/companies/almr.md) (CIK 2104204)
- Form: SCHEDULE 13D/A
- Filed: 2026-07-07
- Accepted by EDGAR: Jul 7, 2026, 16:55 ET
- Period: not reported
- Accession: 0001875620-26-000010
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2104204/000187562026000010/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2104204/000187562026000010/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2104204/000187562026000010/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Jul 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001875620-26-000010. Last ingested by Listed: Nov 15, 2026, 04:11 ET. No prices; not investment advice.
